Newborn screening, BD, NCBDDD, CDC

ï»¿

Birth Defects

Newborn Screening and Related Conditions

• Storage and use of residual dried blood spots from state newborn screening programs
• Mortality Among Children with Sickle Cell Disease Identified by Newborn Screening During 1990-1994 -- California, Illinois, and New York
• Update: Newborn Screening for Sickle Cell Disease --- California, Illinois, and New York, 1998
• Sickle Hemoglobin (Hb S) Allele and Sickle Cell Disease
• Newborn screening for sickle cell disease: public health impact and evaluation
• Barriers to dietary control among pregnant women with phenylketonuria
• The epidemiology of medium chain acyl-CoA dehydrogenase deficiency: an update
• The cost effectiveness of universal versus selective newborn screening for sickle cell disease in the US and the UK: a critique

Date: June 17, 2005
Content source: National Center on Birth Defects and Developmental Disabilities



		Topic Home
		Basic Facts
		Monitoring Birth Defects
		Research
		Prevention
		Genetics

Related Links

Folic Acid

Fetal Alcohol Syndrome

Public Health Genomics

Thank you for visiting the CDC-NCBDDD Web site. Click here to contact the National Center on Birth Defects and Developmental Disabilities

We are not able to answer personal medical questions. Please see your health care provider concerning appropriate care, treatment, or other medical advice.

Pregnancy-Planning Education Program

National Center on Birth Defects and Developmental Disabilities

				Department of Health and Human Services
	Centers for Disease Control and Prevention,1600 Clifton Rd, Atlanta, GA 30333, U.S.A Public Inquiries: 1-800-CDC-INFO (232-4636); 1-888-232-6348 (TTY), 24 Hours/Every Day - cdcinfo@cdc.gov